U.S. Household Products Stock News

In early August 2026, MACOM Technology Solutions Holdings reported third-quarter sales of US$342.24 million and net income of US$100.71 million, sharply higher than a year earlier, alongside significantly improved earnings per share. Over the first nine months of the fiscal year, the company shifted from a net loss to a net profit while also issuing stronger fourth-quarter revenue guidance of US$415 million to US$425 million, highlighting a marked turnaround in financial performance. We'll...

Cooling inflation, softer retail sales and housing strains are pulling markets in two directions, with income investors caught between rate expectations and worries about slower growth. That mix is putting more attention on real estate linked to everyday needs and steady rent checks. This article walks through three U.S. defensive, income focused real estate stocks exposed to these macro shifts and explains why they may deserve a closer look now. The stocks covered below are just a sample of...

Mirum Pharmaceuticals, Inc. reported past earnings for the second quarter and first half of 2026, disclosing a net loss of US$67.23 million for the quarter and a very large six‑month net loss, with basic loss per share from continuing operations rising to US$1.06 for the quarter and US$14.03 for the half year. The sharp widening of losses compared with the prior year highlights how Mirum’s cost base and investment intensity have increased relative to its current revenue scale. We’ll now...

Installed Building Products (IBP) is back in focus after second quarter results topped Wall Street expectations, with commercial installations and recent acquisitions helping offset softer single family residential demand, according to management commentary. See our latest analysis for Installed Building Products. Installed Building Products shares have pulled back in the short term, with the 1 day share price return down 2.38% and the year to date share price return down 10.18%. However, the...

XMax shares inched up about 2% into the weekend, yet the real jolt is in the earnings line. The stock barely moved, while Q2 net income and earnings per share swung sharply into profit, marking a clean break from last year’s losses. The key point is straightforward: XMax has shifted from fighting for survival on the income statement to reporting positive EPS, even as the market still prices the stock on a modest P/E next to peers. Is XMax trading at a genuine earnings reset discount, or has...

In August 2026, AbCellera Biologics Inc. reported positive Phase 2 results for its investigational menopause drug ABCL635 and completed a roughly US$200.00 million follow-on equity offering of common stock and pre-funded warrants. These developments, alongside a new collaboration with Vertex Pharmaceuticals on multispecific T‑cell engagers for autoimmune diseases, highlight AbCellera’s effort to expand its clinical pipeline while strengthening its funding base. We’ll now examine how the...

JetBlue Airways has delivered a 23.1% gain year to date and an 8.2% return over the last year, yet the stock still screens as cheap on several valuation checks after a 60.1% decline over the past five years. For investors looking at JetBlue Airways today, the question is whether the recent share price recovery is beginning to close that gap or if the stock still offers value. Over the past five years, JetBlue Airways shares have declined 60.1%, which suggests the market has already priced in...

Jefferson Capital stock has delivered a 35.5% return over the past year, yet the broader valuation checks point to a mixed picture rather than a clear bargain or clear premium. The 35.5% 1 year return suggests the market has re-rated Jefferson Capital positively. Investors now need to judge whether the current price still leaves enough room for a reasonable upside. Expansion into Latin America and growth in purchased portfolios can support expectations for future collections. At the same...

MacroGenics stock ticked up 3.4% to US$4.22 into the weekend, a modest relief move for a biotech that has been grinding through loss-making quarters and a choppy three month stretch. The headline from this earnings release is not the top line; it is the size of the earnings drag. MacroGenics reported a quarterly loss of US$69.6 million from ongoing operations and basic earnings per share of US$1.10 in the red. For anyone thinking beyond today’s small bounce, the real question is how long this...

In the second quarter of 2026, CareTrust REIT reported higher year-over-year revenue of US$161.35 million and net income of US$89 million, and subsequently raised its full-year 2026 net income guidance to about US$356 million–US$364 million, or US$1.53–US$1.56 per share. This combination of stronger earnings and upgraded guidance comes alongside record second-quarter investment activity at an average yield of 8.9%, highlighting how recent capital deployment is feeding directly into the...

StoneCo stock is coming off a difficult run, with the share price down 76.9% over the past five years, yet the current valuation checks still point to a company that screens cheap on several measures. That gap between weak long term returns and a strong value profile is what many investors are now trying to make sense of. The share price decline of 76.9% over five years shows that long term holders have taken a substantial hit, which often leaves the market cautious about assigning a higher...

In early August 2026, Kimberly-Clark reported slightly higher second-quarter sales of US$4,189 million but lower net income of US$345 million versus a year earlier, affirmed a US$1.28 quarterly dividend, completed its existing share repurchase plan, and earlier announced Suzana Blades will become Senior Vice President and General Counsel effective September 1, 2026. The company also introduced a patented alternative natural fiber program based on the hesperaloe plant, aiming to build a...

Oak Valley Bancorp slipped only 0.5% to about US$34 after its latest earnings, a muted reaction for a community bank that reported another quarter of solid net interest income. The short term story is a slight cooling in per share profit, with basic EPS at US$0.62 for the quarter, while the longer view still shows trailing 12 month earnings of US$2.84 per share and a dividend yield of 2.2%. The key point is margin. A net interest margin of 4.15% keeps Oak Valley Bancorp earning on its loan...

California ports are busy, tariffs are shifting trade routes, and clean energy projects are reshaping how goods move in and out of the country. That mix is creating fresh winners and new risks for companies tied to ports, rail and power systems. This article walks through three stocks from our U.S. Port-Linked Industrial & Clean Infrastructure Stocks screener that appear most exposed to the latest news and explains why that might matter for your portfolio. The stocks covered below are just a...

The market barely reacted to Copper Property CTL Pass Through Trust this week. The stock closed flat at $10.82, even as fresh Q2 numbers highlighted the real pressure point. The story is not the headline earnings per share; it is the squeeze on profitability. Over the last twelve months, net profit margin was 35.9% compared with 77.3% a year earlier. That, plus a large one off loss of $14.8m, has reduced earnings quality. For a yield focused real estate vehicle, that margin compression is the...

In August 2026, Xometry, Inc. reported second-quarter sales of US$229.28 million, sharply reduced its net loss to US$5.31 million, and raised its full-year 2026 revenue growth outlook to 33%–34%, supported by strong marketplace expansion and new third-quarter guidance of US$234 million to US$236 million. The combination of faster marketplace growth and narrowing losses signals that Xometry’s AI-powered manufacturing platform is scaling operationally while still investing heavily for...

With stocks hovering near records and long term Treasuries looking less like a safety net, more investors are parking cash in ultra short bond funds and money market products. That shift in mood could matter for the companies that run these vehicles, as money in motion can reshape fee streams. This article examines three U.S. short duration fixed income product providers that stand out within this trend and explains what their exposure to the news may mean for investors. The three stocks...

Suncrete stock slipped 1.9% to US$18.47 after its Q2 release, but the mild pullback sits awkwardly against what really jarred investors. The headline is the profit squeeze. Revenue reached US$97.23m for the quarter; however, the company reported a net loss of US$48.9m and a basic loss per share of US$0.72. The reaction so far looks more like a shrug than a reset, even though the earnings profile has shifted deeper into the red. Is Suncrete now a misunderstood growth story trading below a...

In early August 2026, EVERTEC, Inc. reported second-quarter 2026 results showing higher sales of US$274.82 million but sharply lower net income of US$5.41 million year-on-year, while also raising full-year 2026 revenue guidance to a range of US$1.09 billion and expanding its share repurchase authorization to US$150 million. Despite the earnings decline, EVERTEC’s decision to increase its revenue outlook and step up buybacks highlights management’s willingness to back the business with...

Talos Energy Inc. recently reported second-quarter 2026 results showing revenue of US$664.81 million and net income of US$149.67 million, alongside updated production guidance for the third quarter and full year 2026 and a new US$77.06 million shelf registration for 5,400,000 common shares tied to an ESOP-related offering. The sharp swing from a net loss in the prior-year quarter to positive earnings, combined with completed share repurchases and higher production levels, highlights how...

DHT Holdings, Inc. reported past second-quarter 2026 results with revenue of US$285.01 million and net income of US$198.34 million, both sharply higher than a year earlier, driving basic and diluted EPS from continuing operations to US$1.23. For the first half of 2026, the company’s revenue of US$471.49 million and net income of US$362.86 million far surpassed the prior year, marking the fastest revenue growth within its infrastructure peer group and outperforming analyst expectations. We’ll...

Credicorp has posted an extremely strong multi year share price gain, yet at around US$386 the stock still screens as undervalued on both its intrinsic value estimate and traditional earnings based multiples. That combination of a big historical return and ongoing valuation upside is what investors now need to weigh. Credicorp has delivered a very large 5 year return of 434.1%, which puts recent short term moves in a much longer context of strong compounding. The valuation story may be...

Seritage Growth Properties walked into this earnings day already on the defensive, with the stock down double digits over the past month and essentially flat at US$2.27 into the print. The market has stopped reacting for now. The business has not. Q2 showed a sharp swing in the income statement, with revenue of US$2.38m and a much smaller loss per share than in Q1. For a company carrying a rich price to sales multiple against other real estate stocks, that shift in the loss line is the...

Hess Midstream (HESM) has drawn investor attention after reporting second quarter 2026 results on 3 August and issuing updated earnings guidance for the third quarter and full year 2026. See our latest analysis for Hess Midstream. Hess Midstream’s share price has climbed 17.0% year to date to US$40.53. The 3 year total shareholder return of 77.7% and 5 year total shareholder return of 151.8% point to momentum that has built over time around its midstream footprint. If this earnings update has...